Abiopharma

NEURAXIS, INC (NRXS)

Symbol	NRXS
Name	NEURAXIS, INC
Sector	UNDEFINED
Region	UNDEFINED
Industry	Electromedical & Electrotherapeutic Apparatus
Address	11611 N. MERIDIAN ST, CARMEL, IN 46032
Telephone	(812) 689-0791
Fax	—
Email	—
Website	—
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001933567
Description	None

2026-08-17 22:38

Director Watkins Bradley Mitchell 🟢 acquired 26.1K shares of Neuraxis, INC (NRXS) at $6.28 Transaction Date: Aug 13, 2026 | Filing ID: 038831

2026-08-17 22:36

Miranda Adrian 🟢 acquired 133.3K shares (1 derivative) of Neuraxis, INC (NRXS) Transaction Date: Aug 13, 2026 | Filing ID: 038829

2026-08-17 22:32

Director Keyser Jane Elizabeth 🟢 acquired 26.1K shares of Neuraxis, INC (NRXS) at $6.28 Transaction Date: Aug 13, 2026 | Filing ID: 038827

2026-08-17 22:30

Henrichs Timothy Robert 🟢 acquired 141.5K shares (1 derivative) of Neuraxis, INC (NRXS) Transaction Date: Aug 13, 2026 | Filing ID: 038824

2026-08-17 22:28

Director Ferge Kristin A 🟢 acquired 31.1K shares of Neuraxis, INC (NRXS) at $6.28 Transaction Date: Aug 13, 2026 | Filing ID: 038821

2026-08-17 22:27

Carrico Thomas Joeseph 🟢 acquired 135.9K shares (1 derivative) of Neuraxis, INC (NRXS) Transaction Date: Aug 13, 2026 | Filing ID: 038819

2026-08-17 22:25

Director Carrico Brian Allen 🟢 acquired 193.3K shares (1 derivative) of Neuraxis, INC (NRXS) Transaction Date: Aug 13, 2026 | Filing ID: 038817

2026-08-17 22:23

Director Aharon Gil 🟢 acquired 86.2K shares of Neuraxis, INC (NRXS) at $6.28 Transaction Date: Aug 13, 2026 | Filing ID: 038815

2026-08-11 11:05

NeurAxis Reports Record Second Quarter 2026 Financial Results Driven by 116% Year Over Year Revenue Growth

2026-08-04 11:00

NeurAxis Expands Payer Coverage with New Policies